Sponsored By

Dr. Mark Ostwald, who served as Chief Technology Officer prior to this appointment, succeeds Dr. Max Kley. He is taking on a leadership role at the newly established battery and fuel cell business group.

June 15, 2022

1 Min Read
Mark Ostwald
Dr. Mark Ostwald, CEO, Freudenberg MedicalImage courtesy of Freudenberg Medical

Dr. Mark Ostwald has been named CEO at Freudenberg Medical. He joined the company in 2009 and served as Chief Technology Officer prior to this appointment. He is also a member of the management board.

Ostwald has held a number of leadership roles at the company, which provides molded and extruded products to medical device OEMs from 11 manufacturing operations worldwide. He has served as president of Europe and head of Minimally Invasive Solutions, vice president and general manager of the Silicones Business Unit in California, and helped establish the Kaiserslautern, Germany, operation as managing director of Freudenberg Medical Europe.

Ostwald follows Dr. Max Kley, who has been appointed CEO of a newly established Freudenberg business group for the battery and fuel cell market.

“I am honored to lead the company at this exciting time of growth,” said Ostwald. “Freudenberg Medical is a great company with innovation at its core. Working with our talented team we will continue to push the envelope with new products and innovative technology to advance healthcare manufacturing and drive value for our customers.”

“Mark is the ideal candidate to lead Freudenberg Medical into the next phase of rapid growth and global expansion,” said Kley. “His strong focus on customer needs, his experience in the medical device industry and his international background ensure that Freudenberg Medical will continue to be a driving force for innovation and quality in the global medical device and pharmaceutical industries.”

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like